Cargando…

Lynch syndrome mutations in Poland and the Baltic States

Detalles Bibliográficos
Autores principales:	Dymerska, Dagmara, Lubinski, Jan, Kurzawski, Grzegorz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565570/ http://dx.doi.org/10.1186/1897-4287-13-S1-A11

Ejemplares similares

Combined iPLEX and TaqMan assays to screen for 45 common mutations in Lynch syndrome and FAP patients
por: Dymerska, D, et al.
Publicado: (2011)

Fast diagnostic test for the identification of an increased genetic predisposition to colon cancer (exemplified on a DNA test for recurrent mutations of the gene MMR)
por: Kurzawski, G, et al.
Publicado: (2012)

Chromosome 8q23.3, 10p14 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome – a combined analysis of the Australian, Dutch and Polish Lynch syndrome cohorts
por: Talseth-Palmer, Bente A, et al.
Publicado: (2012)

Germline deletions in the EPCAM gene as a cause of Lynch syndrome – literature review
por: Tutlewska, Katarzyna, et al.
Publicado: (2013)

HOXB13 mutations and prostate cancer in Poland
por: Kluźniak, Wojciech, et al.
Publicado: (2012)

Mutations spectrum in hereditary disorders predisposing to occurrence of intestine polyposis in Poland
por: Plawski, Andrzej, et al.
Publicado: (2012)

Some aspects of molecular diagnostics in Lynch syndrome
por: Kurzawski, Grzegorz
Publicado: (2006)

Functional in silico analysis of missense mutations in the MSH6 gene
por: Gajdel, Katarzyna, et al.
Publicado: (2015)

State-wide population screening for Lynch syndrome? Improved ascertainment of at risk families
por: Goldblatt, J, et al.
Publicado: (2012)

A rare large duplication of MLH1 identified in Lynch syndrome
por: Kumar, Abhishek, et al.
Publicado: (2021)

A genetic variant in telomerase reverse transcriptase (TERT) modifies cancer risk in Lynch syndrome patients harbouring pathogenic MSH2 variants
por: Wiik, Mariann Unhjem, et al.
Publicado: (2021)

Lynch II syndrome: a case report
por: Scotto, B, et al.
Publicado: (2011)

Meeting abstracts from the Annual Conference on Hereditary Cancers 2016: Szczecin, Poland. 14-15 September 2016
por: Cybulski, C., et al.
Publicado: (2017)

Audit of adherence to GI screening recommendations for Lynch Syndrome Patients
por: Hossack, Lucinda, et al.
Publicado: (2012)

Lynch syndrome (HNPCC)
por: Kładny, Józef, et al.
Publicado: (2008)

A state-wide population-based program for detection of Lynch syndrome based upon immunohistochemical and molecular testing of colorectal tumours
por: Schofield, L, et al.
Publicado: (2012)

Selenium and cancer risk in CHEK2 mutation carriers
por: Gupta, Satish, et al.
Publicado: (2012)

‘PREMM 1,2,6 MODEL’ as a new gene specific prediction model for Lynch Syndrome: retrospective review of mutation positive cases
por: Gale, J
Publicado: (2012)

Cumulative Small Effect Genetic Markers and the Risk of Colorectal Cancer in Poland, Estonia, Lithuania, and Latvia
por: Serrano-Fernandez, Pablo, et al.
Publicado: (2015)

Metachronous colon cancer risk following surgery for first primary rectal cancer in Lynch syndrome
por: Parry, S, et al.
Publicado: (2012)

NBS1 Mutation and prognosis of prostate cancer
por: Wokołorczyk, Dominika, et al.
Publicado: (2012)

Blood and serum samples collection and storage for further selenium measurements
por: Muszyńska, Magdalena, et al.
Publicado: (2012)

Serum concentration of iron as predictor of cancer risk among BRCA1 mutation carriers
por: Sukiennicki, Grzegorz, et al.
Publicado: (2012)

Meeting abstracts from the Annual Conference on Hereditary Cancers 2015: Szczecin, Poland. 24-25 September, 2015
por: Thompson, Ella R., et al.
Publicado: (2017)

Serum concentration of selected macro- and microelements and their correlation with the risk of breast and ovarian cancer among BRCA1 mutation carriers
por: Muszyńska, Magdalena, et al.
Publicado: (2012)

Identification of new genetic alterations in MLH1, MSH2 and MSH6 using IHC and HRM analysis in Lynch syndrome-suspected patients
por: Mazurek, A, et al.
Publicado: (2012)

BRCA1 founder mutations and ovarian cancer in Belarus
por: Savanevich, A, et al.
Publicado: (2015)

African Swine Fever (ASF) and Ticks. No Risk of Tick-mediated ASF Spread in Poland and Baltic States
por: Frant, Maciej, et al.
Publicado: (2017)

RET gene mutations spectrum in patients with medullary thyroid carcinoma (MTC) from Great Poland region
por: Kaczmarek-Ryś, Marta, et al.
Publicado: (2015)

The CHEK 2 GENE mutations and the risk of Gastric cancer
por: Teodorczyk, Urszula, et al.
Publicado: (2012)

Cumulative small effect genetic markers and the detection of advanced colorectal neoplasias by population screening
por: Kurlapska, A, et al.
Publicado: (2012)

Prospective clinical trials on correlations between macro-/ microelements and vitamins and cancer risk
por: Lubinski, Jan
Publicado: (2012)

The risk of breast cancer in women with a CHEK2 mutation
por: Cybulski, Cezary, et al.
Publicado: (2012)

Mutations and polymorphisms of genes moderate increase in gastric cancer risk
por: Teodorczyk, Urszula, et al.
Publicado: (2012)

CHEK2 mutations as markers for high risk of breast cancer
por: Cybulski, Cezary, et al.
Publicado: (2012)

The influence of selenium concentration and variations in selenoprotein genes on the CHEK2-dependent cancers
por: Gupta, Satish, et al.
Publicado: (2015)

Selenium and gastrointestinal cancers risk
por: Lener, Marcin, et al.
Publicado: (2012)

Identification of patients at high risk of negative psychological consequences associated with BRCA1 mutation
por: Ertmański, S, et al.
Publicado: (2012)

Selenium and the risk of cancers of the colon, pancreas and stomach
por: Lener, Marcin, et al.
Publicado: (2012)

DNA and RNA analyses in detection of genetic predisposition to cancer
por: Kurzawski, Grzegorz, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_o4uo3f2ud7jcj56m9ib0ncmo2t